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In order to learn whether or not the therapeutic effect of helenine is specific 
and  limited  to  activity  against  Columbia  SK  encephalomyelitis virus,  or 
whether  it might have a  broader  therapeutic spectrum and exert  its action 
aga~st other viruses, a  study was undertaken of its activity against Semliki 
Forest virus. This agent was selected because, like the SK virus, it is lethally 
infective  when  given  to  mice,  either  subcutaneously or  intraperitoneally, 
and in adequate dosage  can be expected  to kill every animal. Furthermore, 
the period of approximately 3  days between infection and illness allows suffi- 
cient time for  a  therapeutic agent to  exert  its effect.  In addition, so  far  as 
known, the virus is not pathogenic for man and hence is safe for use in large 
scale therapeutic experimentation. 
Materials and Methods 
Vir~s.--The  Semliki Forest  virus  used in these  experiments was initially isolated  by 
Smithburn and Haddow (1). For present purposes it was obtained from Dr.  W. F. Friede- 
wald of Atlanta, Georgia. It is lethally pathogenic for white mice of the Carworth Farms 
CFW strain in high  titre when  administered  either  subcutaneously  or intraperitoneally. 
In the present experiments, infections to be treated  with helenine were induced by the sub- 
cutaneous inoculation, under the loose skin of the back, of 0.5 cc. of a dilution of virus con- 
taining from I0 to  1000 times the amount that regularly killed all untreated control ani- 
mals.  In most  of  the  experiments this  amounted  to  a  1  ×  10  -t to  1  X  10  "a  dilution 
of infected mouse brain. Pools of brains from about 10 infected mice, harvested when some 
were dead, and the remainder showed characteristic  signs of infection, were prepared in 5 
per  cent  suspension  in  buffered saline  (pH  7.3) and  divided  among  a  number  of 
screw-capped vials for storage frozen under CO~ until ready for use. Kept in this way the 
virus retained  an adequate potency and a single batch was sufficient for 3 to 4 months of 
experimental work. Dilution of the virus suspension to the concentration desired in an indi- 
vidual experiment was made just prior to use and the diluted virus was kept in an ice bath 
during the time of its administration. 
All of the helenine preparations  tested  against  Semliki Forest  virus were administered 
intraperitoneally  usually in divided doses 3 and 24 hours after infection. In this way there 
was little chance that the helenine would exert any direct in vitro effect on the subcuta- 
neously administered virus. 
Tests of mold preparations  for antivirai activity against Semliki Forest  virus were con- 
ducted in very much the same manner as those previously outlined for SK virus (2). 
627 628  AN  ANTIVIRAL  SUBSTANCE  ]~ROM P.  ]~UNICULOSUM. II 
Mice to be used were placed 6 to a  cage, and control or treated groups comprised from 
1  to  S  such cages; that is, from 6 to 30 animals per group. Mice dying during the first 48 
hours after infection were not included in the experimental results but rather were ascribed 
as toxic deaths.  Mice dying from the 3rd day after infection onward were considered to have 
succumbed of Semliki Forest virus infections. 10 days was selected as the period of observa- 
tion since it has been our experience that mice living this long were likely  to  survive in- 
definitely. 
Deaths were recorded in the same  manner as for the SK virus experiments. Dead ani- 
mals were collected twice daily and, for statistical purposes,  the deaths  were grouped for 
each 24 hour period recording the deaths found at the afternoon reading with those of the 
following morning. Mice surviving beyond the 10th day were, for purposes of calculating the 
survival index, scored as having succumbed on the 10th day. 
A  statistical evaluation of the results on the same basis as that employed  in the experi- 
ments with SK virus (2)  was complicated by the large numbers of animals, infected with 
Semliki Forest  virus, that were saved by treatment with helenine. While the survival in- 
dexes (SI) were calculated as in the SK virus experiments they are not believed to represent 
the therapeutic efficacy  of given preparations as accurately in the case of Semliki  Forest 
virus as they did with SK virus infections. A  more correct evaluation of the results in ex- 
periments yielding so many survivors seemed to be on the basis of actual  survivors result- 
ing from treatment, and in most of the tables included in the present paper both survival 
indexes and number of survivors will be given. 
Because the tests were performed with groups of  12,  18, or 24 animals regularly it was 
possible to simplify their statistical evaluation. Dr. W. H. Ott has calculated the minimum 
significant differences between survival or mortality rates in groups of 12, 18, or 24 animals 
each  (at 5 per cent probability of such differences occurring due to chance alone)  to be 6 
animals in the case of groups of 12, 7 animals in the case of groups of 18, and 9 animals in 
the case of groups of 24 (3). Thus, to take an example, if in groups of 18 treated and 18 un- 
treated control mice, 2 control mice survived, then 9 treated mice would have to be saved to 
achieve a  minimum significant result and, if 5  of the 18 control mice survived, then 12 of 
the 18 treated mice would have to be saved. This difference of 7 animals up  and down the 
series would thus constitute the minimum significant difference for groups of 18 animals. 
Effect of Helenine  upon Semliki Forest Virus Infection in Mice 
In a  preliminary experiment 5 groups of 24 mice each were infected subcutaneously with 
Semliki Forest virus. One control group was injected intraperitoneally with sterile culture 
medium 3 and 24 hours after infection while the other 4 groups were similarly injected with 
various preparations of helenine. The results are shown in Table I. 
As shown in Table I, 2 of 24 control mice survived, while of the groups treated with SPS 
(superuatant fluid of pellicles fragmented in a  Waring blendor (2))  1 had 7  and the other 
9  survivors with survival indexes respectively of 1.36  and 1.42.  The 2  groups treated with 
acetone precipitates of  the SPS  preparations reconstituted to  double the initial SPS  con- 
centrations, each had  15  survivors and survival indexes of  1.67  and  1.65.  The results ob- 
tained in the groups treated with SPS were thus significant when calculated on the basis of 
survival indexes but not when considered on the basis of number of survivors. The results 
obtained with acetone-precipitated material on the other hand were highly significant, when 
calculated either on the basis of survival index or number of survivors. 
This  experiment  made  it  quite  clear  that  helenine  exerted  a  favorable 
therapeutic  effect  upon  Semliki  Forest  virus,  just  as  it was  known  to  do  in 
the  case  of  SK  virus.  Further,  since  the  amount  of  helenine in  the acetone- RICHARD E.  SHOPE  629 
precipitated material was approximately double that in the SPS,  the superior 
therapeutic result achieved by the former suggested a  progressively favorable 
dosage  response  to  increasing amounts of  helenine in  Semliki Forest  virus 
TABLE I 
Effect of Helenine upon Semliki Forest Virus Infection in Mi~e 
Culture No. 
Therapeutic activity  against Semllki  Forest Virus 
SPS  AP  2  X$  srs~ 
Survival index  Survivors  Survivors  Survival  index 
BC 26  7/24§  15/24  1.67 
BC 26A  9/24  15/24  1.65 
I 
Controls, average days survived  =I 
5.3 ..........................  2/24 
* SPS, supernatant fluid of pellicles fragmented in a  Waring blendor  (2). 
:~ SPS AP 2 X, Acetone precipitate  of SPS redissolved in an amount of distilled water 
equal  to one-half the volume of SPS from which precipitated. 
§  Surviving mice 
No.  of  mice in group 
TABLE II 
Role of Size of Infecting  Dose of Virus on  Tkerapeuti~ Effect Ackieved by Hdenine against 
Semliki Forest Virus Infectious in Mice 
Dilution  of infected brain 
1X10  ~ 
1×10 ~ 
1 X  10  -7 
1X10  -~ 
1X10  -~ 
1 ×  10  -a° 
Controls 
No. of survivors  in each group of 12 mice 
Treated* 
0 
0 
0 
5 
12 
12 
0 
6 
10 
12 
12 
12 
Survival  index 
1.19 
1.39 
2.22 
1.33 
1.0 
1.0 
* Treated  intraperitoneally  with  acetone-precipitated  helenine  3  and  24  hours  after 
subcutaneous infection. 
infections. The subject of dosage response will be considered in greater detail 
later in the experiments to be presented in Table IV. 
Role  of Size  of Infecting  Dose  of  Virus  on  the  Therapeutic  Effect  Achieved  by 
Treatment with Helenine 
In our  experiments,  both  with  SK  virus and with  Semliki Forest  virus, 
we  have  endeavored to  use  an  infecting dose  lying somewhere  between  10 630  AN  ANTIVIRAL  SUBSTANCE  I~RO~  P.  ~UNICULOSIY~.  II 
and 1000 times that which will kill all or almost all the untreated control mice. 
In order  to learn  whether  the apparent  therapeutic  effectiveness  of helenine 
against  Semliki  Forest  virus  might  be  modified  by  variation  in  the  initial 
infecting  dose  of virus,  experiments  of  the  type  outlined  in  Table  II have 
been carried out. 
In the experiment shown in Table H, 6 groups of 24 mice each were infected subcuta- 
neously with 0.5 cc. doses of Serul~kl Forest virus diminishing by progressive ten-time  dilu- 
tions. One-half of the mice infected with each virus dilution were injected intraperitoneally 
with sterile medium 3 and 24 hours  after  infection and designated as controls. The other 
half were treated  intraperitoneaUy with an acetone precipitate  of SPS BC 48-49 3 and 24 
hours after  infection. This acetone precipitate  had been reconstituted  in distilled water  to 
the volume of the original SPS from which derived. 
As  can  be  seen  from  the  results  presented,  helenine  exerted  a  favorable 
therapeutic  effect against the infections produced by the  10  -e,  10  -7, and  10  -~ 
dilutions  of  Semllki  Forest  virus.  The  results  obtained  at  these  3  dilutions 
were significant whether calculated on the basis of survival indexes or actual 
numbers  of survivors.  At  the  10  -~  dilution  the  virus  killed  all  of both  the 
treated  and untreated  animals with  a  survival  index  of 1.19  for the  treated 
group  which  was  just  under  the  minimum  for  significance.  The  10  -9  and 
10  -1°  dilutions  of virus  failed  to kill  any  of the  control  animals  and  hence 
had  no  application  in  the  experiment  except  to  indicate  that  the  limit  of 
dilution of the virus had been reached. 
Comparison  of the Antiviral  Activities  of  the Fluid  Portions  and  Pellicles of 
Stationary Cultures of P. funiculosum 
Although it had been clearly shown (2)  that the pellicles of P. funiculosum 
were  considerably  more  active  against  SK  virus  than  the  fluid  portions  of 
cultures  it  seemed worth while  to  establish  that  a  similar  situation  held  in 
the case of Semliki Forest virus.  Several tests of the comparative therapeutic 
activity  of the  SPS  with  the  fluid  portions  of  cultures  were  made  and  the 
results of one such experiment are shown in Table Ill. 
As shown in Table HI, the fluid portions of stationary cultures of P. funiculosum saved 
only  1 animal out of 2 groups of 18 mice infected with Semllkl Forest  virus.  Despite  this 
poor showing on the basis of saving lives, both fluid preparations  yielded significant sur- 
vival indexes; one 1.29 and the other  1.44. The two SPS on the other hand showed very 
high survival indexes, 1.81 and 1.94, and, in addition, each preparation  saved a significantly 
large number of mice, 8 and 10 out of the 2 groups of 18. The results obtained with the ace- 
tone precipitates of the two SPS reconstituted to the original volume of SPS from which they 
were derived roughly equalled those with  the  SPS.  Diluted  4  times,  these  acetone  pre- 
cipitates, while considerably less active than when undiluted,  still possessed some therapeutic 
activity, judged on the basis of survival indexes, and even at this dilution appeared to be more 
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It  seems  clear from this  and  similar  experiments  carried  out with  Semliki 
Forest virus  that  there  is much more helenine  in,  or in intimate  association 
with,  the  cellular  constituents  of  the  pellicles  of  stationary  cultures  than 
there  is in the  culture fluid itself.  These findings with  Semiliki  Forest Virus, 
therefore, parallel those with SK virus (2). 
Dosage Response to Helenine 
An indication  that mice infected with  Semliki  Forest virus  exhibit  a  dos- 
age response to helenine was suggested by the experiments outlined in Tables 
I  and III. It seemed of interest to determine whether, as it did with SK virus, 
TABLE  III 
Comparative Antidral  Adidty  of Fluid Portions  and  Pdlicles of Stationary  Cultures of P. 
funiculosum  against Seraliki Forest Virus Infections  in Mice 
Activity against Semliki Forest virus 
Culture No.  Fluid  SPS  SPS AP 1 X  SPS AP 0.25 X 
56 
57 
Controls,  average 
days survived  -- 
4.3 ............ 
Survivors 
0/18" 
1/18 
0/24 
SI  Survivors  SI 
1.29  8/18  1.81 
1.44  10/18  1.94 
Survivors  SI 
6/18  1.71 
14/18  2.07 
Survivo~  SI 
2/18  1.77 
2/18  1.53 
*  Surviving Imce 
No.  of  mice  in  group 
the  helenine  therapeutic  effect  would  tend  to  "plateau"  with  large  doses. 
The experiments outlined in Table IV were carried out to learn whether this 
was the case. 
In the experiments recorded  in Table  IV,  two series of tests of acetone precipitates  of 
SPS in dosages ranging from 11 to 0.55 mg. were conducted. The two series were identical 
except for the fact that the reconstituted  precipitate  had in one case been filtered through a 
Seitz pad, while in the other the preparation  was not filtered prior to use. In addition,  a 
third series of tests with an acetone precipitate  of SPS in dosages ranging from 5.72 to 0.022 
rag. was carried out. 
Based on a  consideration of the survival indexes,  both of the first two series 
of tests gave therapeutically significant results at all doses tried and, as in the 
experiments  with  SK  virus,  there  was  a  plateauing  of  effect  at  the  larger 
doses.  In the  third  series a  definite  break  in the  therapeutic  effect came be- 
tween a  dosage of 0.36 and 0.09 rag. 
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TABLE  IV 
Response to Various Doses of Helenine of Mice Infected with Semliki Forest Virus 
Acetone precipitate  of SPS culture 
BC 56-59 unfiltered 
BC 56-59 Seitz filtered 
Total dose* 
mg. 
11.0 
5.5 
2.75 
1.37 
0.55 
11.0 
5.5 
2.75 
1.37 
0.55 
Result of treatment 
Survivors 
11/18~ 
6/18 
6/18 
5/18 
5/18 
12/18 
10/18 
10/18 
8/18 
2/18 
Controls, average days survived -- 5.0.  0/24 
BC63  5.72 
1.~ 
0.36 
0.~ 
0.022 
8/12 
3/12 
1/12 
0/12 
0/12 
Controls, average days survived --  5.4..  2/24 
Survival index 
1.88 
1.71 
1.73 
1.52 
1.48 
1.85 
1.86 
1.76 
1.74 
1.33 
1.69 
1.29 
1.39 
0.99 
0.87 
* Administered intraperitoneally in two equal amounts 3 and 24 hours after subcutaneous 
infection with Semliki Forest virus. 
Surviving mice 
No.  of  mice  in  group 
TABLE  V 
Influence of Time of Administration  of Helenine on Its Therapeugic E.~cacy against Semliki 
Forest Virus 
Time of treatment*  Survival index  No. of mice surviving  of 24 
3 hours before infection ..................... 
3  "  after  "  ..................... 
12  "  "  " 
18  "  "  " 
24  "  "  " 
1.84 
1.62 
1.46 
1.21 
1.24 
1.10 
15 
13 
10 
10 
9 
3 
Controls, average days survived =  5.1 ..........  !  1 
* Single intraperitoneal injection of 5.5 mg. dose of acetone precipitate  SPS culture BC 
56-59  (Seitz  filtered). ~C~_gD x.  s~oPr.  633 
clear  cut.  Based on  the first series of tests with unfiltered acetone-precipi- 
tated material only the  11  mg. dose saved a  significant number of animals. 
The results with filtered acetone precipitate were somewhat better and here 
the 1.37 nag. dose gave a  significant number of survivors. In the third series 
of tests, also with unfiltered materials, 5.72  rag.  saved a  significant number 
of animals while 1.43 mg. did not. Even on the basis of survivors, however, 
a plateauing of effect at higher dosage was apparent. 
The Influence of Time of Administration  of ttelenine  on Its Therapeutic E.ficacy 
against Semtiki Forest Virus 
Preliminary experiments with Semliki Forest virus infections in mice indi- 
cated that, as previously found in the case of SK virus  (2),  single doses of 
helenine large  enough  to  fall within  the  plateau  zone  of maximum  effect, 
given  3  hours  after  infection,  exerted  as  favorable a  therapeutic  effect as 
two such doses given 3 and 24 hours after infection. In order to learn how 
long after infection a  single large dose of helenine would exert a  therapeutic 
effect, groups of 24 mice were treated intraperitoneally at various intervals 
before or after infection subcutaneously with a  surely fatal dose of Semliki 
Forest virus. The results are shown in Table V. 
From the  experiment outlined in Table  V,  it  can be  seen  that helenine, 
given either 3 hours before or 3 hours after infection, exerted a  good thera- 
peutic effect against Semliki Forest virus. There was some falling off in effect 
when  treatment was  delayed 6  and  12  hours.  Even  at  18  hours,  however, 
helenine exerted a  significant therapeutic effect. Treatment delayed 24 hours 
was not significantly effective in therapeutically influencing the virus infec- 
tion. These results parallel very closely those gotten in similar experiments 
with SK virus (2).  As in the case of SK virus also, treatment after obvious 
signs of infection are apparent is without effect. 
The  Effect  of Modification  of Medium  on  the Production  of Helenine  Active 
against Semliki Forest Virus 
In the case of both SK and Semliki Forest virus infections, enrichment of 
the medium by increasing the amounts of glucose and yeast extract, or aging 
of the pellicle mash before final processing to SPS, did not increase the yield 
by P. funiculosum  of helenine. Furthermore, gelatin could be substituted in 
the  medium for yeast extract  and  various  sugars  for glucose without ma- 
terially  altering  the  therapeutic  effectiveness,  against  either  virus,  of  the 
helenine produced. The results of a  typical experiment in which media modi- 
fied in  various ways was employed to  produce  the  helenine tested  against 
Semliki Forest virus are shown in Table VI. 
As shown by the findings recorded in Table VI, 3 of the 4 cultures tested 
had therapeutic activity in their fluid portions when judged on the basis of 
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maltose had  been  substituted  for glucose  (MY).  All four  of  the  SPS  were 
active on the basis of survival indexes and the two containing maltose (MY 
and MG)  on the basis of number of survivors.  The helenine  activity of all 
four SPS,  regardless of the media on which produced,  could be precipitated 
with  acetone,  and,  as in similar experiments with  SK virus,  the  amount of 
solid  material  precipitable  with  acetone  was  less  from  SPS  derived  from 
media containing  gelatin  than from that  containing yeast extract.  The con- 
clusion to be drawn from the results outlined is that gelatin can be substituted 
TABLE VI 
Production of Hdenlne in Media Modified in Various Ways--Tkerat~eutiv Effect Tested against, 
S~nliki Forest Virus* 
Survivors and survival indexes 
Culture 
No.  Broth  SPS  SPS AP 1 X  Medium 
Survivors 
BC 50  DY~t  2/12§  ] 
BC 51  DG  4/12  ] 
BC S2  MY  0/12  I 
~CS3  MG  I  1/12  I 
SI 
1.46 
2.05 
1.19 
1.47 
Controls, average days survived ~- 4.3.. 
Survivors  SI 
4/12  1.84 
5/12  1.67 
7/12  1.92 
8/12  2.11 
0/30 
Survivor~  SI 
6/12  1.93 
3/12  1.78 
6/12  1.88 
2/12  1.62 
Acetone 
preclpltable 
solidsper 
cc. SPS 
m&. 
4.0 
1.57 
4.5 
2.47 
*  Infected subcutaneously and treated  intraperitoneally  3 and 24 hours after  infection. 
D¥, regular  medium containing dextrose and yeast extract;  DG, regular medium in 
which gelatin  was substituted  for yeast extract;  MY, regular  medium in which maltose was 
substituted for dextrose;  MG, regular  medium in which maltose and gelatin  were substi- 
tuted for dextrose and yeast extract. 
§  Mice surviving 
No.  of  mice in  group" 
for yeast extract and maltose for glucose in media in which helenine,  active 
against Semliki Forest virus, is produced. 
Effect of Helenine upon Neuroinvasiveness of Seraliki Forest Virus 
In  the  work  with  SK  virus  (2)  evidence  was  presented  indicating  that 
helenine had an in vivo action either on the rate of multiplication of the virus 
or on its rate of invasion of the central nervous system of infected mice. In 
order to learn whether it had a  similar action on Semliki Forest virus an ex- 
periment like that done with SK virus was conducted. 
In this experiment 62 mice  were infected subcutaneously with an ordinarily fatal dose of 
Semliki Forest virus. 23 of these were set aside as controls and were given 2 intraperitoneal 
injections of sterile medium 3 and 23 hours after infection. The remaining 39 animals were RICHARD E. SHOPE  635 
injected intraperitoneally with a  known effective preparation of helenine as an acetone pre- 
cipitate 3  and 23 hours after infection. 24 hours after infection and thereafter at intervals 
of  24  hours  for  a  total  of  4  days  in  the  case  of  the  controls  and  5  days  in  the 
case of the treated mice several animals of each group were sacrificed by cervical fracture. 
The control mice and I  treated mouse that died on the 4th day were included in the test 
along with those that were sacrificed on the 4th day. 
The  brain  of  each  mouse  was  removed  aseptically promptly  after  sacrifice  or  death, 
ground in a  mortar and suspended in buffered saline (pH 7.3)  to make a  5 per cent suspen- 
sion by wet brain weight. A portion of each brain suspension was injected intraperitoneally 
in 0.5 cc.  dosage into 3  or 4  mice to test for the presence of virus and the remainder was 
stored frozen in the CO2 box in screw-capped vials for possible later titration of virus con- 
tent. If all the mice in a test group lived and appeared normal at the end of a  10 day period 
of observation the brain under test in that group was considered to have been free of virus. 
On  the other hand, death of all mice in a  test group with signs typical of Semlild Forest 
virus infection was considered evidence that the brain under test had contained virus. An 
approximate titration of the amount of virus present was made in some cases by injecting 
groups  of  3  or  4  mice  intraperitoneally with  progressive  tenfold dilutions of  the  stored 
frozen  virus.  The virus titre was  considered  to  be the greatest dilution of infected brain 
killing all the mice in a  group. The result obtained in testing the brains of treated and con- 
trol mice for the presence of virus is recorded in Table VII. 
The  findings' outlined  in  Table  VII  indicate  a  striking  difference  in  virus 
content between the brains of untreated  and  treated mice. 
Of the series of untreated control mice sacrificed from 1 to 4 days after infection or dead 
on  the  4th  day,  the  brain  of  only  1  was  free  of  virus.  This  animal  had  been  sacri- 
riced 24 hours after infection and to judge from the result,  virus had not yet reached its 
brain from the site of subcutaneous inoculation. The brains of all the remaining 15 control 
mice contained virus in varying amounts. 
In the series of mice treated with helenine, on the other hand, virus was not demonstra- 
bly present in the brains of any of those killed 1 day after infection. Of the 7 treated mice 
killed 2 days after infection the brains of 2 contained virus in the same relatively low titre 
as shown by the brains of control animals killed on the corresponding day. The brains of the 
other 5 treated mice killed on the 2nd day were free of virus. Of the 7 treated mice killed 
3 days after infection, virus was present in the brain of only 1 animal. 1 treated mouse was 
found dead 4 days after infection and 6 others were sacrificed. Virus was present in the brain 
of the mouse that died but not in the brains of any of the 6 animals sacrificed. 4  treated 
mice were sacrificed on the 5th day after infection. Virus was present in the brain of 1 and 
not in the brains of the other 3. 
Only 17 of the 23 control mice in the experiment are recorded in Table VII.  Of the  re- 
maining  6  animals,  1  died  on  the  3rd,  3  on  the  4th,  1  on  the  6th,  and  1  on  the 
7th days after infection. Of the 10 treated mice in the experiment not recorded in the table, 
1 died on the 4th, 1 on the 5th, 2 on the 6th, and 1 on the 7th day after infection, while the 
remaining 5 survived the 10 day period of observation. 
From  the  findings  presented  it  would  appear  that  treatment  of  Semliki 
Forest  virus  infections  with  helenine  exerts  either  a  marked  delaying  effect 
upon  the  neuroinvasiveness  of  the  virus  or  an  actual  curative  effect  on  the 
virus infection itself.  That  the effect  is probably  a  curative  one  is suggested 
by  the  irregular  distribution,  from  the  standpoint  of  time  with  regard  to TABLE Vll 
Presence of Semliki Forest Virus in lie Brains of Treated and Control Mice Sacrificed or Dead at 
Various Times ~ "ter Subcutaneous Infection 
Control mouse  No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
Treated mouse  No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Time after infection 
days 
1 
1 
1 
2 
2 
2 
2 
2 
2 
3 
3 
3 
3 
4 
4 died 
4  " 
4  c~ 
1 
1 
1 
1 
2 
2 
2 
2 
2 
2 
2 
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infection,  of  the  cases  in  which  virus  was  demonstrable  in  the  brains  of 
treated animals.  Excluding  treated mouse  19  which  died,  virus  was  found 
in the brains of 2 mice on the 2nd day,  1 on the 3rd day, and 1 on the 5th 
day  after infection while  it  was  absent  in  the  brains  of the  remaining  24 
treated mice sacrificed from 1 to 5 days after infection. This irregular distri- 
bution of brains  containing virus would suggest rather that  the virus infec- 
tion had been cured in the majority of the treated mice than that the agent 
had merely been  delayed in  its  invasion of the  central nervous system,  as 
had  clearly been  the  case with  SK virus  (2).  It seems quite possible,  com- 
paring  these  Semliki  Forest  virus  experiments  with  similar  ones  with  SK 
virus (2), that the mode of therapeutic action of helenine on the two viruses 
may be quite different or that helenine is considerably more effective quan- 
titatively against Semliki Forest virus than it is against SK virus. 
DISCUSSION 
Much of the work with Semliki Forest virus reported in this paper is con- 
finnatory of  similar  experiments  with  the  SK  virus  outlined  in  an  earlier 
paper  (2)  and would appear  to indicate  that  the  therapeutic effect exerted 
by helenine may be directed against members of an as yet undefined group 
of viruses rather than against  only one specific agent.  In this respect it be- 
haves similarly to the established antibiotics, all of which influence infection 
with  several  to  many  species  of bacteria  of  diverse  types  and  pathogenic 
activities. 
Against Semliki Forest virus helenine exerted a  therapeutic effect that was 
somewhat more clear cut, from the standpoint  of apparent cures,  than was 
the case in SK virus infections, in which its therapeutic effect was,  in most 
instances,  largely manifested only by a  prolongation of life.  At  first  sight 
this might seem to indicate that the mechanism by which helenine acted was 
different in  these  two virus  infections,  and  this  possibility  cannot be ruled 
out with certainty from the information available. However, it might equally 
well be that  the  differences in  therapeutic effect were entirely quantitative, 
and this would seem the more likely case from the information presented in 
an  accompanying paper  (4)  in which  comparative therapeutic  tests against 
the two viruses are described. The action of helenine against  Semliki Forest 
virus would seem to have been a  twofold one; first of delaying or preventing 
the  entrance  of  the  virus  into  the  central  nervous  system,  and  second,  of 
destroying the virus, frequently in such a  manner as to prevent the acquisi- 
tion of any viral immunity by the cured host. In the case of SK virus, on the 
other  hand,  only  the  first  phase  of  helenine  effect was  usually  observed, 
namely  that  of  delaying  the  invasion  of  the  central  nervous  system.  The 
second  phase,  actual  destruction  of  SK  virus,  was  achieved  with  relative 
infrequency. The differences in end-result, prolongation of life in most cases 638  AN"  ANTIVIRAL  SUBSTANCE  :FROM P.  FUNICITLOSU~.  II 
of SK virus infections and actual cures in many cases of Semliki Forest virus, 
probably  reflect certain  differences in  the  pathogenic  characters  and prop- 
erties of the two viruses more than they do actual qualitative differences in 
the therapeutic effect of helenine against the two agents. 
As was the case with SK virus infections, helenine appeared to exert little 
if any therapeutic  effect in  mice  suffering massive  infections with  Semliki 
Forest virus.  The  most  significant results  were  obtained in  treating  infec- 
tions caused by from 10 to  100 surely fatal doses of the virus. For optimal 
therapeutic effect the helenine had to be given within 12 hours of the time 
of infection though some effect is apparent when treatment has been delayed 
for 18 hours. Plateauing of effect with large doses of helenine was observed 
in Semliki Forest virus infections, just as it was with SK virus, and in order 
to  demonstrate a  dosage  response  it was  necessary to  use  relatively small 
amounts of helenine well below the maximum tolerated dose. 
Modification of the medium in which helenine is produced, variations in 
the methods by which it is extracted from pellicles,  and any of the  other 
dodges tried to enhance its yield by P. funiculosum gave results with Seraliki 
Forest virus that very closely paralleled those obtained with SK virus. These 
findings  indicate  that  the  substance  found  to  be  therapeutically  active 
against  Semlild Forest virus  was  in  all  likelihood the  same  one  that had 
been found effective against SK virus. There is nothing to indicate that our 
results were due to two different materials produced by P. funiculosum, one 
active against SK and the other against Semliki Forest virus.  So far as can 
be told from our data, helenine, a single entity, was responsible for the ther- 
apeutic action against both viruses. 
SUMMARY 
Helenine exerts a  therapeutic effect against Semliki Forest virus infections 
of mice. Cures, that is to say the survival of treated animals, were more fre- 
quently observed in  Semliki Forest virus  infections than they were  in  SK 
virus  infections.  It  is  believed  that  this  difference in  end-result  probably 
represented only a  quantitative difference in the therapeutic effect of hele- 
nine against these two viruses and not a qualitative difference in its mecha- 
nism of therapeutic action. 
The findings reported in this paper with regard to the treatment of Semliki 
Forest virus infections with helenine parallel very closely those described in 
an accompanying paper which deals with the action of helenine on SK virus 
infections. 
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